Stock comparison
AMN Healthcare Services
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
AMN
AMN Healthcare Services
Market cap
$1.07B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | AMN | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 27F | 77B | LMAT |
| Benjamin Graham | 27F | 89A | LMAT |
| Philip Fisher | 25F | 81C | LMAT |
| Peter Lynch | 17F | 67B | LMAT |
| Joel Greenblatt | 42D | 56D | LMAT |
| Charlie Munger | 20F | 68D | LMAT |
| Terry Smith | 12F | 69D | LMAT |
Side-by-side metrics
| Metric | AMN | LMAT |
|---|---|---|
| Market cap | $1.07B | $2.23B |
| P/E (TTM) | - | 37.1x |
| EV/EBIT | 38.0x | 36.6x |
| ROIC (TTM) | -2.26% | 9.43% |
| Gross margin | 27.63% | 72.39% |
| Net margin | -0.95% | 24.35% |
| Revenue CAGR 5y | -9.01% | 12.75% |
| EPS CAGR 5y | - | 19.04% |
| Debt / Equity | 1.1x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AMN leads on
- P/E (TTM)-vs 37.1x+187%
LMAT leads on
- Revenue CAGR 5y12.75%vs -9.01%+171%
- ROIC (TTM)9.43%vs -2.26%+124%
- Net margin24.35%vs -0.95%+104%
- Dividend yield0.84%vs 0.0%+100%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.